The California Institute for Regenerative Medicine (CIRM) has overcome start-up challenges, been selectively influenced by criticism, and ultimately has adhered to its core mission, according to a new UCSF analysis published in the January issue of the American Journal of Public Health (AJPH). UCSF researchers Joel W. Adelson, MD, PhD, MPH, and Joanna K. Weinberg, JD, LLM, both with the UCSF Institute for Health & Aging, School of Nursing, interviewed major stakeholders—supporters and opponents—and analyzed documents and meeting notes for the analysis.